CHOP Researchers Use Human Stem Cells to Model a Severe Epilepsy Syndrome and Identify a Potential Targeted Treatment
Nov 21, 2023
An experimental compound might be further developed as an effective treatment approach for affected patients.
<p>Beckwith-Wiedemann syndrome (BWS) is a rare genetic disorder characterized by overgrowth. The syndrome occurs in 1 in 11,000 births.</p>
Nov 21, 2023
An experimental compound might be further developed as an effective treatment approach for affected patients.
Nov 20, 2023
Alexis Thompson, MD, MPH, received the award at the society’s annual meeting.
Nov 17, 2023
Shortly after giving birth at Thomas Jefferson University Hospital, Meredith Alley found herself visiting her son, Graham, in the neonatal intensive care unit (NICU). He had arrived earlier than expected and faced respiratory distress that required special care.
Nov 28, 2023
Check out the list of resources from the CDC and AAP, including interim recommendations for use of nirsevimab during the current shortage and updated Red Book chapter on use of PCV20.
Nov 28, 2023
Published by UNESCO, this report presents five principles for governing digital platforms moving forward. Check it out!
Nov 28, 2023
Find general requirements for informed consent before vaccination and specific requirements for COVID-19 and RSV.
Nov 28, 2023
Vaccine-induced thrombotic thrombocytopenia (VITT) has been shown to follow vaccination with COVID-19 adenovirus vector vaccines. Now, two research studies have shown that VITT also follows adenovirus infection. Find out more.
Nov 28, 2023
Find out how societal protection is at the mercy of local protection, and access multiple reports about local, national and global vaccine coverage.
Nov 16, 2023
Researchers found CAR T-cell therapy may serve as effective alternative for patients with these disorders.
Nov 16, 2023
Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.